.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Fish and Richardson
Covington
Deloitte
Daiichi Sankyo
Express Scripts
Dow
Argus Health
Fuji
Cipla

Generated: June 27, 2017

DrugPatentWatch Database Preview

Etodolac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for etodolac and what is the scope of etodolac patent protection?

Etodolac
is the generic ingredient in three branded drugs marketed by Sandoz, Apotex Inc, Mylan Pharms Inc, Teva, Mylan, Apotex, Oxford Pharms, Wyeth Pharms Inc, Ani Pharms Inc, Ranbaxy Labs Ltd, Eci Pharms Llc, Watson Labs Florida, Zydus Pharms Usa Inc, Idt Australia Ltd, Chartwell Molecules, Watson Labs, Taro, Taro Pharm Inds, Ivax Sub Teva Pharms, and Actavis Elizabeth, and is included in thirty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for etodolac. Thirty-seven suppliers are listed for this compound.

Summary for Generic Name: etodolac

Tradenames:3
Patents:1
Applicants:20
NDAs:35
Drug Master File Entries: see list22
Suppliers / Packagers: see list37
Bulk Api Vendors: see list56
Clinical Trials: see list25
Patent Applications: see list8,668
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etodolac at DailyMed

Pharmacology for Ingredient: etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
ETODOLAC
etodolac
TABLET;ORAL074903-002Apr 19, 1999ABRXNoNo► Subscribe► Subscribe
Idt Australia Ltd
ETODOLAC
etodolac
CAPSULE;ORAL074840-002Aug 29, 1997DISCNNoNo► Subscribe► Subscribe
Idt Australia Ltd
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075943-001Jul 26, 2002DISCNNoNo► Subscribe► Subscribe
Actavis Elizabeth
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL075696-001Jul 31, 2000DISCNNoNo► Subscribe► Subscribe
Taro
ETODOLAC
etodolac
TABLET, EXTENDED RELEASE;ORAL076174-002Mar 13, 2003ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
LODINE
etodolac
CAPSULE;ORAL018922-003Jan 31, 19914,076,831► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-001Oct 25, 19964,966,768*PED► Subscribe
Wyeth Pharms Inc
LODINE
etodolac
CAPSULE;ORAL018922-002Jan 31, 19913,939,178► Subscribe
Wyeth Pharms Inc
LODINE
etodolac
CAPSULE;ORAL018922-003Jan 31, 19913,939,178► Subscribe
Wyeth Pharms Inc
LODINE XL
etodolac
TABLET, EXTENDED RELEASE;ORAL020584-003Jan 20, 19984,966,768*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Dow
Farmers Insurance
Express Scripts
Citi
Queensland Health
Harvard Business School
Accenture
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot